Catalyst Wire Dossier Catalyst Wire Dossier

CAR-T Cell Therapy for Desensitization

Chimeric antigen receptor T-cell therapy · National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR-T Cell Therapy for Desensitization, covering 2025-11-26 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: CAR-T Cell Therapy for Desensitization in Kidney Transplantation [Phase 1]

See pricing